Business Context and Reporting Period
This Form 8-K Current Report was filed by IMPACT BIOMEDICAL INC. on September 16, 2026. The filing serves as a Regulation FD disclosure regarding the company's submission of a Form F-4 registration statement. This registration statement is in connection with a proposed merger with Zoar Limited (formerly known as Dr Ashleys Limited).
Key Financial Metrics
The filing text does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. This report focuses exclusively on the procedural status of the proposed business combination.
Material Changes
The primary material event reported is the filing of the Form F-4 registration statement for the proposed merger with Zoar Limited. No other material changes to financial position or operations are detailed in this specific document.
Guidance, Outlook, and Risks
- Transaction Status: A preliminary proxy statement/prospectus has been filed by Zoar Limited. A definitive version will be mailed to stockholders once the registration statement is declared effective.
- Stockholder Action: A special meeting of stockholders will be held to vote on the business combination. The record date for this meeting is to be established by the board of directors.
- Forward-Looking Statements: The filing includes standard cautionary language regarding risks and uncertainties that could cause actual results to differ materially from expectations, referencing risk factors in the company's Form 10-K and Form 10-Q.
- Participants: Impact Biomedical, Zoar Limited, Zoar Labs, and their respective directors and executive officers are deemed participants in the proxy solicitation.
Investor Verification Checklist
- Verify the contents of the Form F-4 Registration Statement and the preliminary proxy statement/prospectus filed by Zoar Limited for detailed merger terms.
- Monitor for the announcement of the record date and the schedule for the special stockholder meeting.
- Review the definitive proxy statement/prospectus once available for updated information on the business combination.
- Check the company's most recent Form 10-K and Form 10-Q for detailed financial performance and risk factors not included in this 8-K.